Discussion  by unknown
22
2
2
2
2
3
3
3
3
3
3
3
3
JOURNAL OF VASCULAR SURGERY
August 2011446 Sultan et alcalf compression on popliteal artery hemodynamics: a comparative
study. J Vasc Surg 2000;32:284-92.
10. van Bemmelen PS, Mattos MA, Faught WE, Mansour MA, Barkmeier
LD, Hodgson KJ, et al. Augmentation of blood flow in limbs with
occlusive arterial disease by intermittent calf compression. J Vasc Surg
1994;19:1052-8.
11. van Bemmelen PS, Weiss-Olmanni J, Ricotta JJ. Rapid intermittent
compression increases skin circulation in chronically ischemic legs with
infra-popliteal arterial obstruction. VASA 2000;29:47-52.
12. Labropoulos N, Cunningham J, Kang SS, Mansour MA, Baker WH.
Optimising the performance of intermittent pneumatic compression
devices. Eur J Vasc Endovasc Surg 2000;19:593-7.
13. Belcaro G, Vasdekis S, Rulo A, Nicolaides AN. Evaluation of skin blood
flow and venoarteriolar response in patients with diabetes and peripheral
vascular disease by laser Doppler flowmetry. Angiology 1989;40:953-7.
14. HusmannM,Willenberg T, KeoHH, Spring S, Kalodiki E, Delis KT, et
al. Integrity of venoarteriolar reflex determines level of microvascular
skin flow enhancement with intermittent pneumatic compression. J
Vasc Surg 2008;48:1509-13.
15. Chen LE, Liu K, Qi WN, Joneschild E, Tan X, Seaber AV, et al. Role of
nitric oxide in vasodilation in upstream muscle during intermittent
pneumatic compression. J Appl Physiol 2002;92:559-66.
16. Liu K, Chen LE, Seaber AV, Urbaniak JR. Influences of inflation rate
and duration on vasodilatory effect by intermittent pneumatic compres-
sion in distant skeletal muscle. J Orthop Res 1999;17:415-20.
17. Strejcek J, Arkans E. Intermittent Pneumatic Compression Therapy for
peripheral Arterial Occlusive Disease. Phlebol Digest 2004;17:5-8.
18. Lowery AJ, Hynes N, Manning BJ, Mahendran M, Tawfik S, Sultan S.
A prospective feasibility study of duplex ultrasound arterial mapping,
digital-subtraction angiography, and magnetic resonance angiography
in management of critical lower limb ischemia by endovascular revascu-
larization. Ann Vasc Surg 2007;21:443-51.
19. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes
FG; et al. Inter-Society Consensus for the Management of Peripheral
Arterial Disease (TASC II). Eur J Vasc Endovasc Surg 2007;II:33:
S1-S75.
20. Ouriel K, Fiore WM, Geary JE. Limb-threatening ischemia in the
medically compromised patient: amputation or revascularization? Sur-
gery 1988;104:667-72.
21. Veith FJ, Gupta SK, Samson RH, Scher LA, Fell SC, Weiss P, et al.
Progress in limb salvage by reconstructive arterial surgery combined
with new or improved adjunctive procedures. Ann Surg 1981;194:386-
401.
22. Hickey NC, Thomson IA, Shearman CP, Simms MH. Aggressive
arterial reconstruction for critical lower limb ischaemia. Br J Surg
1991;78:1476-8.23. Dormandy J, Heeck L, Vig S. The fate of patients with critical leg
ischemia. Semin Vasc Surg 1999;12:142-7. S
of patients that we have to better understand the characteristics a little
b
(
w
t
t
c
w
s
o
p
d
a
y
d
s4. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes
FG, et al; and the TASC II Working Group. Inter-society consensus
for the management of peripheral arterial disease. Int Angiol 2007;
26:81-157.
5. Pohjolainen T, Alaranta H. Lower limb amputations in southern Fin-
land 1984-1985. Prosthet Orthot Int 1988;12:9-18.
6. Eskelinen E, LutherM, Eskelinen A, LepäntaloM. Infrapopliteal bypass
reduces amputation incidence in elderly patients: a population based
study. Eur J Vasc Endovasc Surg 2003;26:65-8.
7. Husmann M, Willenberg T, Keo H, Spring S, Kalodiki E, Kostas T.
Integrity of venoarteriolar reflex determines level of microvascular skin
flow enhancement with intermittent pneumatic compression. J Vasc
Surg 2008;48:1509-13.
8. Wahlberg E, Jörneskog G, Olofsson P, Swedenborg J, Fagrell B. The
influence of reactive hyperemia and leg dependency on skin microcir-
culation in patients with peripheral arterial occlusive disease (PAOD),
with and without diabetes. VASA 1990;19:301-6.
9. Cisek PL, Eze AR, Comerota AJ, Kerr R, Brake B, Kelly P, et al.
Microcirculatory compensation to progressive atherosclerotic disease.
Ann Vasc Surg 1997;11:49-53.
0. Delis KT, GiannouKas AD. Intermittent pneumatic compression (IPC)
in the treatment of peripheral arterial occlusive disease (PAOD). A
useful tool or just another device? Eur J Vasc Endovasc Surg 2007;33:
309-10.
1. Delis KT, Lennox AF, Nicolaides AN, Wolfe JH. Sympathetic autoreg-
ulation in peripheral vascular disease. Br J Surg 2001;88:523-8.
2. Husmann MJ, Barton M, Jacomella V, Silvestro A, Amann-Vesti BR.
Long-term effects of endovascular angioplasty on orthostatic vasocuta-
neous autoregulation in patients with peripheral atherosclerosis. J Vasc
Surg 2006;44:993-7.
3. Hickey NC, Wilkes MP, Howes D, Watt J, Shearman CP. The effect of
epidural anaesthesia on peripheral resistance and graft flow following
femorodistal reconstruction. Eur J Vasc Endovasc Surg 1995;9:93-6.
4. The ICAI, Study Group. Prostanoids for chronic critical leg ischemia. A
randomized, controlled, open-label trial with prostaglandin E1. Ann
Intern Med 1999;130:412-21.
5. The Iloprost Bypass International Study Group. Effects of perioperative
iloprost on patency of femorodistal bypass grafts. Eur J Vasc Endovasc
Surg 1996;12:363-71.
6. Abu-Own A, Cheatle T, Scurr JH, Coleridge Smith PD. Effects of
intermittent pneumatic compression of the foot on themicrocirculatory
function in arterial disease. Eur J Vasc Surg 1993;7:488-92.
7. Van Bemmelen P, Char D, Giron F, Ricotta JJ. Angiographic improve-
ment after rapid intermittent compression treatment (ArtAssist) for
small vessel obstruction. Ann Vasc Surg 2003;17:224-8.ubmitted Dec 4, 2010; accepted Feb 24, 2011.DISCUSSION
DrAlanDardik (NewHaven, Conn). Dr Sultan, did you have
any other options besides the ArtAssist device for this patient,
something like stem cell therapy or growth factor therapy?
Dr Sherif Sultan. Regarding stem cell therapy, we haven’t
applied it in our practice yet due to prohibitory national regula-
tions. However, it might soon be an option. But the results from
clinical trials that have been conducted have been far from con-
vincing. Stem cell therapy is still in its infancy and it has a long way
to go before it forms a cornerstone of our treatment. That said,
some of the cultured stem cells are showing some promise but are
still far away from applying to clinical practice.
Dr Hasan Dosluoglu (Buffalo, NY). Very good results, but I
am very confusedwith the results because it looks not only better than
primary amputation but better than those who undergo revascular-
ization. As a matter of fact, the reported survival is better than
claudicants in our series. It seems tome that this is a very unique groupetter, because, as I said, it is not your typical critical limb ischemia
CLI) group, just by looking at the 68% 5-year survival rate.
Dr Sultan. First of all, these patients are very high risk. From
hen you first see them in your clinic, these are the guys that have
he sign on them saying “do not touch!” And basically if you don’t
ouch them, they’ll survive until they are going to die from their
ardiovascular comorbid-laden problems. One of the reasons that
e have a good outcome is because these patients die from
omething else rather than dying from their legs. And this is borne
ut in the Kaplan-Meier curves. The minute you touch these
atients they die, and this is evident from the 12 patients that we
id intervene on, all of them are dead. That is the problem. They
re very fragile and there is no way back for them.
Dr Hisham Bassiouny (Chicago, Ill). Can you elaborate on
our strategy to maintain patient compliance for applying the
evice three times daily for 1 hour during the duration of the
tudy?
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the morning and 3 hours in the evening. And some patients use it
more than that and are very compliant. One of the major things
that we discovered is that when you offer it to the patient, you have
to give them at least 2 to 3 days in the hospital to give them the
opportunity to build a “friendly relationship” with the machine. If
you give them the machine as an outpatient, they’re usually afraid
of using it. But the minute they get their heads around it, they fare
out brilliantly. In fact, some of my patients have already bought
this machine and they don’t want to give it back to the company.
Dr Peter Gloviczki (Rochester, Minn). If I understood your
data correctly, the results are as good as with open revasculariza-
tion. So do you still perform open revascularization in those who
are suitable for distal bypass?
Dr Sultan. We are very aggressive with our CLI program and
are fully committed to thoracic endovascular aneurysm repair
(TEVAR) revascularization, whether angioplasty alone or laser
angioplasty. Revascularization remains our prime aim for these
patients. We only offer the ArtAssist machine, because of our
problem with funding, to patients that are not suitable for TEVAR
if they have absolutely no runoff vessel or they are very high risk.
Dr Dardik. So if you can tell us, these patients all had only
distal disease or did they have, for example, superficial femoral
artery occlusion and then you were unable to revascularize them?
Dr Sultan. These patients, when you do your duplex, there is
no runoff vessel traveling from the distal calf to the ankle and the
toes. That’s the first thing.
n
9The other thing that we have found is that a patent popliteal
rtery is crucial for the success of the use of this. The inflow-
utflow is a problem, but definitely the presence of a patent
opliteal is the only way that you can ensure the successful use of
his machine.
Dr Dardik. Any contraindications to use of this machine?
Dr Sultan. Severe congestive cardiac failure and deep vein
hrombosis (DVT) are two of the major contraindications and that
s why we usually keep some of our patients in the hospital initially
ust to offload a few liters of fluid out of their body before we put
he machine on, otherwise you could drive into acute pulmonary
dema. DVT is definitely a contraindication.
Dr Samir Issa (Riyadh, Saudi Arabia). We passed on very
ast the changes in the toe brachial index. Could you please
laborate on the objective change in this parameter? Did you
otice any improvement in the toe brachial index after using this
evice?
Dr Sultan. There is a theory that there is a vascular plegia
roblem in the precapillary area in these patients, especially in
iabetics. Evidence has shown that when an epidural or prostaglan-
in is given to these patients that there is peripheral vasodilatation
nd the patients benefit tremendously. We measure the digital
ressure and we measure laser Doppler values in these patients.
lthough we don’t have a full set of data from the laser Doppler,
e do have a complete set of ankle brachial indices and the digital
ressures. The ankle brachial indices have improved significantly in
ondiabetic patients. While digital pressures have improved after
0 days in all patients who completed the program.
